Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles.

Christensen BC, Marsit CJ, Houseman EA, Godleski JJ, Longacker JL, Zheng S, Yeh RF, Wrensch MR, Wiemels JL, Karagas MR, Bueno R, Sugarbaker DJ, Nelson HH, Wiencke JK, Kelsey KT.

Cancer Res. 2009 Aug 1;69(15):6315-21. doi: 10.1158/0008-5472.CAN-09-1073.

2.

Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome.

Christensen BC, Houseman EA, Godleski JJ, Marsit CJ, Longacker JL, Roelofs CR, Karagas MR, Wrensch MR, Yeh RF, Nelson HH, Wiemels JL, Zheng S, Wiencke JK, Bueno R, Sugarbaker DJ, Kelsey KT.

Cancer Res. 2009 Jan 1;69(1):227-34. doi: 10.1158/0008-5472.CAN-08-2586.

3.

Asbestos burden predicts survival in pleural mesothelioma.

Christensen BC, Godleski JJ, Roelofs CR, Longacker JL, Bueno R, Sugarbaker DJ, Marsit CJ, Nelson HH, Kelsey KT.

Environ Health Perspect. 2008 Jun;116(6):723-6. doi: 10.1289/ehp.11151.

4.

Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma.

Christensen BC, Godleski JJ, Marsit CJ, Houseman EA, Lopez-Fagundo CY, Longacker JL, Bueno R, Sugarbaker DJ, Nelson HH, Kelsey KT.

Carcinogenesis. 2008 Aug;29(8):1555-9. doi: 10.1093/carcin/bgn059.

Supplemental Content

Loading ...
Support Center